Ihab Shawish

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Positive Breast Cancer

Angiotensin Converting Enzyme

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Hassan H Hammud, Waleed A Aljamhi, Ihab Shawish, Nur Hazimah B Z Arfan, Malai Haniti S A Hamid, Nadeem S Sheikh, Hany M Abd El-Lateef, Assem Barakat, Matti Haukka
Experimental and Computational Anticorrosion Behaviors of Pyrazole s -Triazine/anilino-morpholino Derivatives for Steel in Acidic Solutions. ACS omega 9 (29) (2024)
Ihab Shawish, Samha Al Ayoubi, Mohamed Bououdina, Abeer A El-Segaey, Alia A Melegy, Ayman M Atta
New Functionalized Di-substituent Imidazolium Ionic Liquids as Superior Faster Absorbents for Carbon Dioxide Gas. ACS omega 9 (19) (2024)
Hassan H Hammud, Waleed A Aljamhi, Ihab Shawish, Nur Hazimah B Z Arfan, Malai Haniti S A Hamid, Nadeem S Sheikh, Hany M Abd El-Lateef, Assem Barakat, Matti Haukka
Experimental and Computational Anticorrosion Behaviors of Pyrazole s -Triazine/anilino-morpholino Derivatives for Steel in Acidic Solutions. ACS omega 9 (29) (2024)
Ihab Shawish, Samha Al Ayoubi, Mohamed Bououdina, Abeer A El-Segaey, Alia A Melegy, Ayman M Atta
New Functionalized Di-substituent Imidazolium Ionic Liquids as Superior Faster Absorbents for Carbon Dioxide Gas. ACS omega 9 (19) (2024)
Salman Ali Khan, Alamgir Khan, Komal Zia, Ihab Shawish, Assem Barakat, Zaheer Ul Haq
Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein. International journal of molecular sciences 23 (18) (2022)
Ihab Shawish, Assem Barakat, Ali K Aldalbahi, Walhan Mohammad Alshaer, Fadwa Daoud, Dana A Alqudah, Mazhar Salim Al Zoubi, Ma'mon M Hatmal, Mohamed S Nafie, Matti Haukka, Anamika Sharma, Beatriz G de la Torre, Fernando Albericio, Matti Haukka
Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s -Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades. Pharmaceutics 14 (8) (2022)